Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is a synthetic peptide medicine, meaning it is built in a laboratory rather than extracted from a natural source. Scientists construct it by linking amino acids in a precise sequence, then chemically modifying the chain so it can activate two gut-hormone receptors at once. It is a prescription-only medicine in the UK, and a prescriber must assess clinical suitability before it can be supplied. If you have been reading about tirzepatide and wondering exactly what you would be injecting, that curiosity is worth taking seriously — this page explains the manufacturing science in plain terms.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people pick up their first Mounjaro KwikPen and feel a flicker of the same question: what, precisely, is this thing I am about to inject? Tirzepatide is not a vitamin, a hormone harvested from an animal, or a plant extract. It is a purpose-built peptide, a short protein-like chain that Eli Lilly's chemists designed from the ground up to mimic two naturally occurring gut hormones, GIP and GLP-1. Those hormones are released after eating and help regulate appetite, blood-sugar response, and gastric emptying. The natural versions are broken down in the bloodstream within minutes. Tirzepatide is engineered to survive much longer, which is why one pen lasts a week.
The molecule consists of 39 amino acids arranged in a specific order. That sequence was chosen because it binds to both the GIP receptor and the GLP-1 receptor, making tirzepatide the only dual-agonist weight-management medicine licensed in the UK. A small fatty-acid side chain is then attached to the peptide backbone; this tether binds the molecule loosely to albumin proteins in the blood, slowing its clearance and enabling that once-weekly injection schedule. Understanding what tirzepatide is made of helps explain why the dosing works the way it does, slow release, sustained effect. You can read more about the individual ingredients in Mounjaro, including the excipients in the KwikPen formulation.
Pharmaceutical peptides like tirzepatide are produced using a technique called solid-phase peptide synthesis (SPPS). The chemist starts with a solid resin bead and adds amino acids one at a time, in the correct order, using a series of controlled chemical reactions. Each coupling step is checked before the next amino acid is added. Once the full 39-amino-acid chain is assembled it is cleaved from the resin, purified through high-performance liquid chromatography to remove any impurities or incorrectly assembled fragments, and then the fatty-acid modification is added. The resulting substance is a white-to-off-white powder. That powder is dissolved and formulated into the sterile solution you see in the pen cartridge, alongside excipients that stabilise the molecule and make injection comfortable, things like a buffer, a preservative, and water for injection. Eli Lilly manufactures Mounjaro at licensed facilities subject to Good Manufacturing Practice (GMP) regulations, and the finished product reaches UK pharmacies through the authorised UK supply chain. Every batch undergoes release testing before it is distributed.
This manufacturing rigour is one reason counterfeit versions of tirzepatide pens are so dangerous. The MHRA has warned publicly that fake pens seized in the UK have contained entirely different substances, including insulin, a consequence of buying from sellers operating without a valid pharmaceutical licence. If you want to check that any pharmacy supplying you is legitimate, the GPhC register lists every legally operating UK pharmacy by name and premises number.
Once injected, tirzepatide gradually releases from the albumin-binding tether and activates GIP and GLP-1 receptors in the gut, pancreas, and brain. The GLP-1 pathway suppresses appetite and slows gastric emptying; GIP adds complementary effects on fat metabolism and may improve tolerability of the GLP-1 component. Activating both at once produces greater average weight reduction in clinical trials than activating either pathway alone. In the SURMOUNT-1 study, published in the New England Journal of Medicine, participants taking the highest dose lost around 20 to 21 percent of body weight on average over 72 weeks, results the NICE committee cited in its appraisal of tirzepatide, NICE TA1026, when recommending it for adults in England who meet specific BMI and clinical criteria.
That dual mechanism is also why tirzepatide's side-effect profile is worth understanding, slower gastric emptying means some people feel nausea, particularly in the early weeks or after a dose increase. Those effects are a direct consequence of how the molecule works, not a sign that something has gone wrong with manufacture. More detail on what tirzepatide consists of at the molecular level is available if you want to go deeper into the chemistry. The key practical point is that every component, from the amino-acid chain to the pen cartridge materials, is defined precisely in the product's Summary of Product Characteristics.
Because tirzepatide is a peptide, it is sensitive to temperature. The formulated solution in the KwikPen must be refrigerated between 2°C and 8°C. There is a limited window during which the pen can be kept at room temperature, but for the exact figures you should check the Patient Information Leaflet inside your packaging or the Mounjaro Summary of Product Characteristics on the eMC, never rely on a rough number from a blog. Freezing the pen damages the molecule and the pen must not be used afterwards. Equally, the pen should not be exposed to direct sunlight or left on a windowsill. Many patients keep the pen in the fridge door, which works well as long as the fridge temperature is stable, somewhere between the butter dish and the milk tends to be about right.
The pen itself is a pre-filled, single-use device. Each pen delivers four weekly doses of the same strength. The manufacturing process produces a sterile, ready-to-use solution, so there is no mixing required. If you are thinking about starting treatment and want to understand whether tirzepatide is clinically appropriate for you, our free consultation page explains the assessment process. A prescriber at our GPhC-registered pharmacy reviews every consultation personally, the same day it is submitted. For a broader look at the Mounjaro treatment page or to understand how private costs compare, the Mounjaro price comparison guide sets out what different providers typically include. If you have questions that are not covered here, the FAQs page covers common queries, or you can get in touch directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.